Results 121 to 130 of about 8,428 (249)
, 2019 Idiopathic intracranial hypertension (IIH) is commonly seen related to iatrogenic causes such as excess retinol, tetracyclines, and amiodarone. We report a case of IIH likely related to mesalamine use.
Mehta, Dev +2 more
core
Acute pancreatitis associated with mesalamine: A case report and review of the literature
, 1996 Mesalamine, widely used in the treatment of chronic inflammatory bowel disease, has been associated in some patients with the development of acute pancreatitis.
GALLERANI M. +11 more
core
Mesalamine Administration in Allergic Patients with Inflammatory Bowel Disease [PDF]
, 2006 James J. Yoo, Katherine Gundling
openalex +1 more source
Mesalamine Microemulsions for Crohn’s Disease: A Review
oai:ojs.ijhse.com:article/1This analysis delves into the promise of mesalamineencapsulated microemulsions in improving bioavailability and therapeutic effectiveness for Crohn\u27s disease. Crohn’s disease, a persistent inflammatory condition of the bowel,
Subham Mandal, Suraj Mandal
core +1 more source
Inhibition of Colon Carcinogenesis by 2-Methoxy-5-Amino-N-Hydroxybenzamide, a Novel Derivative of Mesalamine [PDF]
, 2009 Carmine Stolfi +9 more
openalex +1 more source
Immunotherapy withdrawal by step‐down to mesalamine in pediatric patients with ulcerative colitis [PDF]
Réka Szigeti, Richárd Kellermayer
openalex +1 more source
Stability Enhancement of Mesalamine Delayed-Release Tablets 1.2g
Mesalamine (5-aminosalicylic acid) is widely used for the treatment of inflammatory bowel disease (IBD), including ulcerative colitis. Commercially available mesalamine delayed-release formulations, such as LIALDA (Mesalamine) Delayed-Release Tablets 1.2
Anonymous,
core
Mesalamine (5-ASA) for the prevention of recurrent diverticulitis [PDF]
, 2017 Flloyd Carter +3 more
openalex +1 more source